Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical and clinical data presented on BEZ-235

Dec. 31, 2010

Bristol-Myers Squibb and Otsuka to copromote Sprycel in Japan

Dec. 30, 2010

Phase I/II trial of belinostat/Tarceva combination in NSCLC advances

Dec. 30, 2010

Ziopharm Oncology treats first patient in phase I trial of palifosfamide

Dec. 30, 2010

New inhibitors of focal adhesion kinase 1 claimed

Dec. 30, 2010

MK-0752 shows promise in patients with breast cancer

Dec. 30, 2010

PharmaGap and Queen's University collaborate to develop GAP-107B8 for bladder cancer

Dec. 29, 2010

Telapristone shows promise in preclinical models of breast cancer

Dec. 29, 2010

Exelixis divulges novel mTORC1 inhibitors

Dec. 29, 2010

New inhibitors of insulin-like growth factor 1 receptor presented

Dec. 29, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...